XNCR
Xencor Inc

733
Mkt Cap
$942.18M
Volume
0.00
52W High
$27.24
52W Low
$6.92
PE Ratio
-5.46
XNCR Fundamentals
50D MA
$10.44
Beta
1.26
Avg. Volume
1.2M
EPS (Annual)
-$3.58
P/B
1.52
Rev/Employee
$441,972.00
Loading...
Loading...
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
250

Frequently Asked Questions

What is Market Cap of Xencor Inc?
What is the 52-week high for Xencor Inc?
What is the 52-week low for Xencor Inc?
What is the PE ratio of Xencor Inc?
What is the Price-to-Book ratio of Xencor Inc?
What is the 50-day moving average of Xencor Inc?
How many employess does Xencor Inc has?

Latest XNCR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.